Abeona Therapeutics - 40 Year Stock Price History | ABEO

Historical daily share price chart and data for Abeona Therapeutics since 1980 adjusted for splits. The latest closing stock price for Abeona Therapeutics as of April 06, 2020 is 2.29.
  • The all-time high Abeona Therapeutics stock closing price was 106250.00 on May 21, 1981.
  • The Abeona Therapeutics 52-week high stock price is 8.41, which is 267.2% above the current share price.
  • The Abeona Therapeutics 52-week low stock price is 1.35, which is 41% below the current share price.
  • The average Abeona Therapeutics stock price for the last 52 weeks is 3.67.
Abeona Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.6383 3.2100 4.0800 1.4500 2.2900 -29.97%
2019 4.8851 7.0300 8.3100 1.5400 3.2700 -54.20%
2018 13.8195 17.2000 21.4500 6.4000 7.1400 -54.95%
2017 9.4940 5.0000 19.9500 4.6000 15.8500 226.80%
2016 3.8948 3.4200 8.7000 2.1000 4.8500 44.35%
2015 4.6488 3.4000 9.8000 2.7700 3.3600 -2.61%
2014 15.8543 12.5000 29.5000 3.4400 3.4500 -72.40%
2013 20.4325 13.5000 30.0000 11.5000 12.5000 4.17%
2012 37.5400 70.0000 72.0000 11.0000 12.0000 -83.33%
2011 100.4960 123.5000 129.5000 66.0000 72.0000 -41.94%
2010 124.7679 160.0000 164.5000 90.0000 124.0000 -24.62%
2009 118.4524 45.0000 235.0000 38.5000 164.5000 232.32%
2008 121.3162 171.0000 175.0000 40.0000 49.5000 -69.54%
2007 229.4980 145.0000 513.0000 120.0000 162.5000 16.07%
2006 66.6733 127.5000 147.5000 5.0000 140.0000 7.69%
2005 446.4286 860.0000 870.0000 130.0000 130.0000 -85.31%
2004 1241.5575 1297.5000 1987.5000 632.5000 885.0000 -32.44%
2003 805.7639 462.5000 1375.0000 437.5000 1310.0000 249.33%
2002 667.0040 1112.5000 1412.5000 287.5000 375.0000 -66.22%
2001 933.9541 1250.0000 1562.5000 575.0000 1110.0000 -11.20%
2000 1363.6225 437.5000 3468.7500 406.2500 1250.0000 150.00%
1999 602.3392 593.7500 1015.6250 289.0750 500.0000 -11.11%
1998 1020.8502 2734.5000 3515.5000 281.2500 562.5000 -79.43%
1997 2824.0356 3906.5000 6094.0000 1015.5000 2734.5000 -27.08%
1996 7465.3228 5312.5000 13437.5000 3750.0000 3750.0000 -29.41%
1995 2601.7520 2969.0000 5625.0000 469.0000 5312.5000 88.89%
1994 4650.6389 5937.5000 8750.0000 2187.5000 2812.5000 -55.00%
1993 10565.7154 15625.0000 16875.0000 5625.0000 6250.0000 -54.55%
1992 17685.7776 15000.0000 28750.0000 11250.0000 13750.0000 -8.33%
1991 7264.0850 2500.0000 16875.0000 2500.0000 15000.0000 500.00%
1990 5326.0909 6250.0000 9375.0000 2500.0000 2500.0000 -55.56%
1989 16593.5020 13750.0000 23125.0000 4062.5000 5625.0000 -59.09%
1988 18102.7668 16875.0000 29375.0000 11875.0000 13750.0000 -12.00%
1987 34473.8142 34375.0000 51250.0000 13125.0000 15625.0000 -52.83%
1986 36534.0909 35000.0000 53750.0000 26250.0000 33125.0000 -5.36%
1985 33970.7341 28750.0000 50000.0000 25000.0000 35000.0000 19.15%
1984 24024.2095 32500.0000 38750.0000 13750.0000 29375.0000 -11.32%
1983 47954.5455 73750.0000 73750.0000 26250.0000 33125.0000 -56.56%
1982 65909.0909 75000.0000 91250.0000 50000.0000 76250.0000 3.39%
1981 77257.9051 66250.0000 106250.0000 56250.0000 73750.0000 11.32%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.175B $0.003B
Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $121.152B 13.85
Gilead Sciences (GILD) United States $98.468B 12.74
CSL (CSLLY) Australia $82.413B 0.00
Vertex Pharmaceuticals (VRTX) United States $61.786B 56.07
Regeneron Pharmaceuticals (REGN) United States $54.274B 22.99
Biogen (BIIB) United States $52.308B 8.93
Illumina (ILMN) United States $38.735B 40.05
Seattle Genetics (SGEN) United States $20.070B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.938B 9.25
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.036B 36.55
BioMarin Pharmaceutical (BMRN) United States $15.152B 647.77
Genmab (GMAB) Denmark $13.158B 10.21
Galapagos (GLPG) Belgium $12.305B 26.87
Alnylam Pharmaceuticals (ALNY) United States $11.965B 0.00
BioNTech SE (BNTX) Germany $11.935B 0.00
Genmab (GNMSF) Denmark $11.706B 37.65
Moderna (MRNA) United States $11.462B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.922B 51.05
QIAGEN (QGEN) Netherlands $9.172B 27.97
BeiGene (BGNE) Cayman Islands $9.117B 0.00
Exact Sciences (EXAS) United States $8.249B 0.00
Sarepta Therapeutics (SRPT) United States $7.281B 0.00
Bio-Techne Corp (TECH) United States $7.148B 48.92
ACADIA Pharmaceuticals (ACAD) United States $6.332B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.965B 15.76
Guardant Health (GH) United States $5.709B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.644B 0.00
Ascendis Pharma (ASND) Denmark $5.347B 0.00
Repligen (RGEN) United States $5.115B 93.53
Exelixis (EXEL) United States $5.045B 16.20
Acceleron Pharma (XLRN) United States $4.309B 0.00
Reata Pharmaceuticals (RETA) United States $4.282B 0.00
China Biologic Products (CBPO) China $3.976B 23.60
Adaptive Biotechnologies (ADPT) United States $3.249B 0.00
Blueprint Medicines (BPMC) United States $3.225B 0.00
Global Blood Therapeutics (GBT) United States $3.203B 0.00
Mirati Therapeutics (MRTX) United States $3.193B 0.00
Vir Biotechnology (VIR) United States $3.184B 0.00
MorphoSys AG (MOR) Germany $3.168B 0.00
Emergent Biosolutions (EBS) United States $2.998B 20.82
Zai Lab (ZLAB) China $2.995B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.837B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.796B 0.00
NeoGenomics (NEO) United States $2.538B 110.04
Amicus Therapeutics (FOLD) United States $2.400B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.396B 40.60
Bluebird Bio (BLUE) United States $2.329B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.90
Halozyme Therapeutics (HALO) United States $2.244B 0.00
Alkermes (ALKS) Ireland $2.228B 176.50
MyoKardia (MYOK) United States $2.160B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.062B 0.00
UniQure (QURE) Netherlands $2.016B 0.00
Immunomedics (IMMU) United States $2.011B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.930B 0.00
Denali Therapeutics (DNLI) United States $1.813B 0.00
Fate Therapeutics (FATE) United States $1.742B 0.00
Alector (ALEC) United States $1.720B 0.00
Amarin (AMRN) Ireland $1.707B 0.00
Principia Biopharma (PRNB) United States $1.610B 0.00
Viela Bio (VIE) United States $1.572B 0.00
Arvinas (ARVN) United States $1.553B 0.00
Eidos Therapeutics (EIDX) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.533B 0.00
Akcea Therapeutics (AKCA) United States $1.471B 31.63
Insmed (INSM) United States $1.428B 0.00
Epizyme (EPZM) United States $1.401B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.320B 0.00
Ligand Pharmaceuticals (LGND) United States $1.209B 37.55
Inovio Pharmaceuticals (INO) United States $1.128B 0.00
PHARMA MAR SA (PHMMF) Spain $1.107B 0.00
Zealand Pharma (ZEAL) Denmark $1.106B 0.00
Editas Medicine (EDIT) United States $1.073B 0.00
Twist Bioscience (TWST) United States $1.065B 0.00
REGENXBIO (RGNX) United States $1.031B 0.00
Coherus BioSciences (CHRS) United States $1.019B 12.13
NextCure (NXTC) United States $0.963B 0.00
Myriad Genetics (MYGN) United States $0.912B 16.10
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
NGM Biopharmaceuticals (NGM) United States $0.844B 0.00
I-Mab (IMAB) China $0.827B 0.00
Beam Therapeutics (BEAM) United States $0.827B 0.00
Novavax (NVAX) United States $0.804B 0.00
Intra-Cellular Therapies (ITCI) United States $0.798B 0.00
Revance Therapeutics (RVNC) United States $0.781B 0.00
Sangamo Therapeutics (SGMO) United States $0.752B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.722B 0.00
Adverum Biotechnologies (ADVM) United States $0.713B 0.00
Cytokineticsorporated (CYTK) United States $0.711B 0.00
Arcus Biosciences (RCUS) United States $0.664B 0.00
Pharming Group (PHGUF) Netherlands $0.663B 0.00
Bellus Health (BLU) Canada $0.662B 0.00
Retrophin (RTRX) United States $0.638B 0.00
GENFIT S.A (GNFT) France $0.620B 0.00
Cara Therapeutics (CARA) United States $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.591B 0.00
Intellia Therapeutics (NTLA) United States $0.586B 0.00
Athenex (ATNX) United States $0.580B 0.00
Codexis (CDXS) United States $0.577B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.551B 4.84
Compugen (CGEN) Israel $0.510B 0.00
AC Immune SA (ACIU) Switzerland $0.507B 12.95
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.500B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.489B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.487B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
Intrexon (PGEN) United States $0.480B 0.00
Athersys (ATHX) United States $0.473B 0.00
Frequency Therapeutics (FREQ) United States $0.471B 0.00
Castle Biosciences (CSTL) United States $0.470B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.469B 0.00
ANI Pharmaceuticals (ANIP) United States $0.463B 8.35
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Sorrento Therapeutics (SRNE) United States $0.450B 0.00
Clovis Oncology (CLVS) United States $0.448B 0.00
MeiraGTx Holdings (MGTX) United States $0.436B 0.00
Scholar Rock Holding (SRRK) United States $0.430B 0.00
Heska (HSKA) United States $0.425B 0.00
Morphic Holding (MORF) United States $0.415B 0.00
Prothena (PRTA) Ireland $0.413B 0.00
DBV Technologies S.A (DBVT) France $0.411B 0.00
Anika Therapeutics (ANIK) United States $0.394B 13.58
Verastem (VSTM) United States $0.391B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.388B 0.00
AnaptysBio (ANAB) United States $0.384B 0.00
UROGEN PHARMA (URGN) United States $0.384B 0.00
Agenus (AGEN) United States $0.383B 0.00
Vericel (VCEL) United States $0.382B 56.67
Xenon Pharmaceuticals (XENE) Canada $0.369B 0.00
BioDelivery Sciences (BDSI) United States $0.365B 42.11
Cellectis S.A (CLLS) France $0.354B 0.00
MiMedx (MDXG) United States $0.354B 0.00
Cue Biopharma (CUE) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.342B 0.00
Kala Pharmaceuticals (KALA) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.329B 9.85
Merus (MRUS) Netherlands $0.305B 0.00
Cellular Biomedicine (CBMG) United States $0.300B 0.00
WAVE Life Sciences (WVE) Singapore $0.285B 0.00
Dynavax Technologies (DVAX) United States $0.273B 0.00
Puma Biotechnology (PBYI) United States $0.273B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.267B 0.00
Syros Pharmaceuticals (SYRS) United States $0.265B 0.00
NantKwest (NK) United States $0.256B 0.00
Kamada (KMDA) Israel $0.255B 10.59
Avid Bioservices (CDMO) United States $0.245B 0.00
Precision BioSciences (DTIL) United States $0.240B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.238B 0.00
Mersana Therapeutics (MRSN) United States $0.238B 0.00
Albireo Pharma (ALBO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
Stemline Therapeutics (STML) United States $0.225B 0.00
Sutro Biopharma (STRO) United States $0.217B 0.00
Seres Therapeutics (MCRB) United States $0.216B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.216B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.210B 0.00
Geron (GERN) United States $0.210B 0.00
Aduro Biotech (ADRO) United States $0.205B 0.00
MannKind (MNKD) United States $0.200B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Alcobra (ARCT) United States $0.197B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.188B 1.69
XOMA (XOMA) United States $0.181B 0.00
VBI Vaccines (VBIV) United States $0.180B 0.00
Starpharma Holdings (SPHRY) Australia $0.180B 0.00
HOOKIPA Pharma (HOOK) United States $0.171B 0.00
Protagonist Therapeutics (PTGX) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.158B 0.00
Prometic Life Sciences (LMNL) Canada $0.156B 0.00
IVERIC Bio (ISEE) United States $0.152B 0.00
OSMOTICA PHARM (OSMT) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Fortress Biotech (FBIO) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.149B 0.00
Spero Therapeutics (SPRO) United States $0.148B 0.00
Aytu Bioscience (AYTU) United States $0.147B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
AIT Therapeutics (XAIR) United States $0.136B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
Kindred Biosciences (KIN) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Biofrontera AG (BFRA) Germany $0.133B 0.00
Theratechnologies (THTX) Canada $0.129B 0.00
Cerecor (CERC) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.123B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.117B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.115B 0.00
VTv Therapeutics (VTVT) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.095B 0.00
Strongbridge Biopharma (SBBP) United States $0.094B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Aptinyx (APTX) United States $0.091B 0.00
OvaScience (MLND) United States $0.089B 0.00
PHASEBIO PHARMA (PHAS) United States $0.082B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Five Prime Therapeutics (FPRX) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.078B 0.00
Orgenesis (ORGS) United States $0.073B 4.27
Clearside Biomedical (CLSD) United States $0.071B 0.00
Cyclerion Therapeutics (CYCN) United States $0.070B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.068B 0.00
Adocia (ADOCY) France $0.066B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Menlo Therapeutics (MNLO) United States $0.063B 0.00
Arbutus Biopharma (ABUS) Canada $0.063B 0.00
Eton Pharmaceuticals (ETON) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.062B 0.00
Emmaus Life Sciences (EMMA) United States $0.061B 0.00
Proteostasis Therapeutics (PTI) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
SESEN BIO, INC (SESN) United States $0.057B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.055B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Synlogic (SYBX) United States $0.052B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.051B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Trevena (TRVN) United States $0.046B 0.00
Catalyst Biosciences (CBIO) United States $0.045B 0.00
Stealth BioTherapeutics (MITO) United States $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
Idera Pharmaceuticals (IDRA) United States $0.038B 0.00
Cocrystal Pharma (COCP) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Lumos Pharma (LUMO) United States $0.032B 0.00
CollPlant Holdings (CLGN) Israel $0.032B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ATyr Pharma (LIFE) United States $0.027B 0.00
Prima BioMed (IMMP) Australia $0.026B 0.00
Celsion (CLSN) United States $0.026B 0.00
Pulmatrix (PULM) United States $0.026B 0.00
Curis (CRIS) United States $0.025B 0.00
Evogene (EVGN) Israel $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.021B 0.00
BioCardia (BCDA) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Alimera Sciences (ALIM) United States $0.019B 0.00
Stellar Biotechnologies (EDSA) Canada $0.018B 0.00
Oncobiologics (OTLK) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
VIVUS (VVUS) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Aptevo Therapeutics (APVO) United States $0.010B 0.00
Unum Therapeutics (UMRX) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TrovaGene (TROV) United States $0.008B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.007B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00